Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27828662 | 0.94 | NPC1 (0.53) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL13023144 | 0.90 | CA12 (0.53) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL5692582 | 0.88 | NPC1 (0.61) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL176369 | 0.86 | CA12 (0.71) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL20572690 | 0.86 | SERPINE1 (0.63) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL20107471 | 0.86 | CA12 (0.53) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL2289482 | 0.86 | NPC1 (0.50) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL23309682 | 0.85 | NPC1 (0.49) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL13314438 | 0.83 | CA12 (0.50) | NPC1CA12CA1CA2CA9 | |
| SCHEMBL9651582 | 0.83 | NPC1 (0.47) | NPC1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627592-A | Curing method of adhesive containing difluoro amino | 南京理工大学 | 2019-12-31 | — | — | CN | claimed |
| EP-3156461-B1 | UV CURABLE INKJET INKS | AGFA NV (BE) | 2020-04-01 | — | — | EP | disclosed |
| CN-110627592-A | Curing method of adhesive containing difluoro amino | 南京理工大学 | 2019-12-31 | — | — | CN | disclosed |
| US-10513620-B2 | UV curable inkjet inks | AGFA NV (BE) | 2019-12-24 | — | — | US | disclosed |
| US-20190071578-A1 | UV CURABLE INKJET INKS | AGFA NV (BE) | 2019-03-07 | — | — | US | disclosed |
| WO-2017063983-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-20 | — | — | WO | disclosed |
| WO-2017064033-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-20 | — | — | WO | disclosed |
| WO-2017063968-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-20 | — | — | WO | disclosed |
| EP-3156463-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| EP-3156462-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| EP-3156461-A1 | UV CURABLE INKJET INKS | AGFA GRAPHICS NV (BE) | 2017-04-19 | — | — | EP | disclosed |
| US-20100181527-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | CIBA CORPORATION | 2010-07-22 | — | — | US | disclosed |
| EP-2162937-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | BASF SE (DE) | 2010-03-17 | — | — | EP | disclosed |
| WO-2008155247-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | BASF SE (CH) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100181527-A1 | NITROXIDE CONTAINING ELECTRODE MATERIALS FOR SECONDARY BATTERIES | CAT, NQO1, NUCB2 | NPC1 4532/4885CA12 1821/4885CA1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.